Bank Of America Corp Intercept Pharmaceuticals, Inc. Put Options Transaction History

Bank Of America Corp

3 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q4 2022 Feb 10, 2023	SELL	$11.61 - $16.11 $206,658 - $286,758	-17,800 Reduced 8.02%	204,100 $2.52 Million
Q3 2022 Nov 14, 2022	BUY	$12.21 - $19.7 $1.83 Million - $2.95 Million	149,700 Added 207.34%	221,900 $3.1 Million
Q2 2022 Aug 12, 2022	BUY	$11.23 - $19.59 $810,806 - $1.41 Million	72,200 New	72,200 $997,000

1.04M

30K

5.9K

Ticker ICPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,127,400
Description
Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination wit...

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

Stay updated on Bank Of America Corp with notifications on news.